|
|
|
|
|
National & World Ag News Headlines |
|
Bayer, Nuvisan Create New Research Units in Berlin
USAgNet - 02/13/2020
Bayer AG announced that it entered into a definitive agreement to transfer a large part of its Berlin-based small molecule research unit to Nuvisan, an international service provider for clinical studies, laboratory services and contract manufacturing with several
sites and clinics in Germany and France.
The strategic partnership will lay the foundation for a brand-new research entity to be established by Nuvisan in Berlin. At the same time, it will support Bayer's increased focus on the flexibility and productivity of its R&D operating model. Financial terms were
not disclosed.
"With Nuvisan we have found an excellent partner with a clear plan to build up a strong full-fledged research unit in Berlin together with our dedicated team of scientists," said Dr. Joerg Moeller, Member of the Executive Committee of Bayer AG's
Pharmaceuticals Division and Head of Research and Development. "Nuvisan shares our vision that the new research center can become an important player in research partnering based on the joint know-how and the capabilities of our highly qualified
scientists."
The Berlin-based research unit with around 400 workplaces comprises of a fully operational team specialized in small molecule research. The research center comes with capabilities and capacities spanning the entire drug discovery value chain, including Lead
Discovery, Medicinal Chemistry, Pharmacology, Drug Metabolism & Pharmacokinetics, Investigational Toxicology, and Animal Management. Bayer will retain significant research activities in Berlin, which remains the headquarters for the company's
Pharmaceuticals Division and one of its major global research sites.
Bayer and Nuvisan will cooperate closely in the coming years to build the new research center. The transaction is expected to close mid of 2020 subject to successful completion of the consultation process with the employee representatives and the preparations
for taking over the research activities.
|
|
|
|
Copyright © 2024 - Farms.com. All Rights Reserved. |
|
|